IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · see citing works

Clinical characteristics of coronavirus disease 2019 in China

Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246 · see citing works

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · see citing works

Dexamethasone in Hospitalized Patients with Covid-19

The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477 · see citing works

COVID-19: consider cytokine storm syndromes and immunosuppression

Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664 · see citing works

Toll-like receptor signalling

Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312 · see citing works

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249 · see citing works

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · see citing works

Endothelial cell infection and endotheliitis in COVID-19

Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358 · see citing works

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413 · see citing works

IL‐6 in inflammation, immunity, and disease

Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016295 · Cited by 5,046 · see citing works

Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

Grupp, S. A., Kalos, M., Barrett, D., Aplenc, R., Porter, D. L., Rheingold, S. R., Teachey, D. T., Chew, A., Hauck, B., Wright, J. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215134 · Cited by 3,509 · see citing works

Interleukin-6 and the acute phase response

Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734 · see citing works

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · see citing works

Effective treatment of severe COVID-19 patients with tocilizumab

Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005615117 · Cited by 2,636 · see citing works

IL-6 as a keystone cytokine in health and disease

Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511 · see citing works

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V, Yudkin, J. S., Humphries, S., & Woo, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2629 · Cited by 2,243 · see citing works

The spectrum of neuromyelitis optica

Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,182 · see citing works

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139 · see citing works

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130 · see citing works

The biology of interleukin-6

Kishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.bloodjournal7411 · Cited by 2,068 · see citing works

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

Brentjens, R. J., Davila, M. L., Riviere, I., Park, J., Wang, X., Cowell, L. G., Bartido, S., Stefanski, J., Taylor, C., Olszewska, M., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005930 · Cited by 2,063 · see citing works

Disseminated Intravascular Coagulation

Levi, M. M., & Cate, H. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410807 · Cited by 2,027 · see citing works

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Abani, O., Abbas, A., Abbas, F., Abbas, M., Abbasi, S., Abbass, H., Abbott, A., Abdallah, N., Abdelaziz, A., Abdelfattah, M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00676-0 · Cited by 1,983 · see citing works

Interleukin-6 receptor antagonists in critically ill patients with Covid-19.

The REMAP-CAP Investigators (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100433 · Cited by 1,962 · see citing works

Cytokine release syndrome in severe COVID-19

Moore, J. B., & June, C. H. (2020) · Science · doi:10.1126/science.abb8925 · Cited by 1,912 · see citing works

Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia

Porter, D. L., Hwang, W.-T., Frey, N. V., Lacey, S. F., Shaw, P. A., Loren, A. W., Bagg, A., Marcucci, K. T., Shen, A., Gonzalez, V., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac5415 · Cited by 1,729 · see citing works

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., et al. (1988) · Nature · doi:10.1038/332083a0 · Cited by 1,633 · see citing works

IL‐6: Regulator of Treg/Th17 balance

Kimura, A., & Kishimoto, T. (2010) · European Journal of Immunology · doi:10.1002/eji.201040391 · Cited by 1,605 · see citing works

Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice

Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,536 · see citing works

Interleukin-6 and chronic inflammation

Gabay, C. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1917 · Cited by 1,468 · see citing works

A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family.

Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S. M., Nishio, Y., Nakajima, T., Hirano, T., & Kishimoto, T. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08316.x · Cited by 1,446 · see citing works

Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6

Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B. F., Broxmeyer, H. E., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,440 · see citing works

Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells

Norelli, M., Camisa, B., Barbiera, G., Falcone, L., Purevdorj, A., Genua, M., Sanvito, F., Ponzoni, M., Doglioni, C., Cristofori, P., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0036-4 · Cited by 1,406 · see citing works

Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

Gust, J., Hay, K. A., Hanafi, L.-A., Li, D., Myerson, D., Gonzalez-Cuyar, L. F., Yeung, C., Liles, W. C., Wurfel, M., Lopez, J. A., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0698 · Cited by 1,400 · see citing works

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396 · see citing works

Trial of tocilizumab in giant-cell arteritis

Stone, J. H., Tuckwell, K., Dimonaco, S., Klearman, M., Aringer, M., Blockmans, D., Brouwer, E., Cid, M. C., Dasgupta, B., Rech, J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1613849 · Cited by 1,386 · see citing works

Interleukin-6 in Biology and Medicine

Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,384 · see citing works

Molecular cloning and expression of an IL-6 signal transducer, gp130

Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., & Kishimoto, T. (1990) · Cell · doi:10.1016/0092-8674(90)90411-7 · Cited by 1,304 · see citing works

Structure and function of a new STAT-induced STAT inhibitor

Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., et al. (1997) · Nature · doi:10.1038/43219 · Cited by 1,287 · see citing works

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Salama, C., Han, J., Yau, L., Reiss, W. G., Krämer, B., Neidhart, J. D., Criner, G. J., Kaplan‐Lewis, E., Baden, R. P., Pandit, L. M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2030340 · Cited by 1,285 · see citing works

CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade

Giavridis, T., van der Stegen, S. J. C., Eyquem, J., Hamieh, M., Piersigilli, A., & Sadelain, M. (2018) · Nature Medicine · doi:10.1038/s41591-018-0041-7 · Cited by 1,272 · see citing works

MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions

Gerszten, R. E., García-Zepeda, E. A., Lim, Y.-C., Yoshida, M., Ding, H. A., Gimbrone, M. A., Luster, A. D., Luscinskas, F. W., & Rosenzweig, A. (1999) · Nature · doi:10.1038/19546 · Cited by 1,242 · see citing works

Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.

Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,181 · see citing works

Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer

Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102 · see citing works

Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia

Teachey, D. T., Lacey, S. F., Shaw, P. A., Melenhorst, J. J., Maude, S. L., Frey, N., Pequignot, E., Gonzalez, V. E., Chen, F., Finklestein, J., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0040 · Cited by 1,102 · see citing works

Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Howard, M., Farrar, J., Hilfiker, M. L., Johnson, B., Takatsu, K., Hamaoka, T., & Paul, W. E. (1982) · The Journal of Experimental Medicine · doi:10.1084/jem.155.3.914 · Cited by 1,099 · see citing works

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., Tedgui, A., Haegeman, G., & Staels, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32048 · Cited by 1,089 · see citing works

Interleukin-6: from basic science to medicine--40 years in immunology.

Kishimoto, T. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115806 · Cited by 1,083 · see citing works

Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) Receptor

Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T., & Kishimoto, T. (1988) · Science · doi:10.1126/science.3136546 · Cited by 1,053 · see citing works

Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor

Cohen, T., Nahari, D., Weiss-Cerem, L., Neufeld, G., & Levi, B.-Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.736 · Cited by 1,038 · see citing works

Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway

Akira, S., Nishio, Y., Inoue, M., Wang, X.-J., We, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., & Kishimoto, T. (1994) · Cell · doi:10.1016/0092-8674(94)90235-6 · Cited by 1,019 · see citing works

Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome

Minegishi, Y., Saito, M., Tsuchiya, S., Tsuge, I., Takada, H., Hara, T., Kawamura, N., Ariga, T., Pasic, S., Stojković, O., et al. (2007) · Nature · doi:10.1038/nature06096 · Cited by 987 · see citing works

Choice of STATs and Other Substrates Specified by Modular Tyrosine-Based Motifs in Cytokine Receptors

Stahl, N., Farruggella, T. J., Boulton, T. G., Zhong, Z., Darnell, J. E., & Yancopoulos, G. D. (1995) · Science · doi:10.1126/science.7871433 · Cited by 979 · see citing works

DAMPening Inflammation by Modulating TLR Signalling

Piccinini, A. M., & Midwood, K. S. (2010) · Mediators of Inflammation · doi:10.1155/2010/672395 · Cited by 976 · see citing works

The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome

Ranucci, M., Ballotta, A., Dedda, U. D., Baryshnikova, E., Poli, M., Resta, M. V., Falco, M., Albano, G., & Menicanti, L. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14854 · Cited by 962 · see citing works

Tocilizumab in patients with severe COVID-19: a retrospective cohort study

Guaraldi, G., Meschiari, M., Cozzi-Lepri, A., Milic, J., Tonelli, R., Menozzi, M., Franceschini, E., Cuomo, G., Orlando, G., Borghi, V., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30173-9 · Cited by 939 · see citing works

Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman’s disease

Yoshizaki, K., Matsuda, T., Nishimoto, N., Kuritani, T., Taeho, L., Aozasa, K., Nakahata, T., Kawai, H., Tagoh, H., & Komori, T. (1989) · Blood · doi:10.1182/blood.v74.4.1360.1360 · Cited by 928 · see citing works

Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study

Goshua, G., Pine, A., Meizlish, M. L., Chang, C.-H., Zhang, H.-M., Bahel, P., Baluha, A., Bar, N., Bona, R., Burns, A. J., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30216-7 · Cited by 918 · see citing works

Targeting Interleukin-6 Signaling in Clinic

Kang, S., Tanaka, T., Narazaki, M., & Kishimoto, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.026 · Cited by 870 · see citing works

Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency

Boisson‐Dupuis, S., Jouanguy, E., Al-Hajjar, S. H., Fieschi, C., Al-Mohsen, I. Z., Aljumaah, S., Yang, K., Chapgier, A. L. A., Eidenschenk, C., Eid, P., et al. (2003) · Nature Genetics · doi:10.1038/ng1097 · Cited by 814 · see citing works

IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation

Kaplanski, G. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(02)00013-3 · Cited by 811 · see citing works

Hyper-IgE Syndrome with Recurrent Infections — An Autosomal Dominant Multisystem Disorder

Grimbacher, B., Holland, S. M., Gallin, J. I., Greenberg, F., Hill, S. C., Malech, H. L., Miller, J., O’Connell, A. C., & Puck, J. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400904 · Cited by 801 · see citing works

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

Jones, G., Sebba, A., Gu, J., Lowenstein, M. B., Calvo, A., Gomez-Reino, J. J., Siri, D. A., Tomšič, M., Alecock, E., Woodworth, T., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.105197 · Cited by 797 · see citing works

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

Maini, R. N., Taylor, P. C., Szechinski, J., Pavelka, K., Bröll, J., Balint, G., Emery, P., Raemen, F., Petersen, J., Smolen, J., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22033 · Cited by 790 · see citing works

Treatment of rheumatoid arthritis with humanized anti–interleukin‐6 receptor antibody: A multicenter, double‐blind, placebo‐controlled trial

Nishimoto, N., Yoshizaki, K., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Hashimoto, J., Azuma, J., & Kishimoto, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20303 · Cited by 786 · see citing works

Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease

Nishimoto, N., Kanakura, Y., Aozasa, K., Johkoh, T., Nakamura, M., Nakano, S., Nakano, N., Ikeda, Y., Sasaki, T., Nishioka, K., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4602 · Cited by 754 · see citing works

Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion.

Poli, V., Balena, R. F., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G. A., & Costantini, F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06368.x · Cited by 745 · see citing works

Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells

Esser, S., Lampugnani, M. G., Corada, M., Dejana, E., & Risau, W. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.13.1853 · Cited by 715 · see citing works

Immunotherapeutic Implications of Il-6 Blockade for Cytokine Storm

Tanaka, T., Narazaki, M., & Kishimoto, T. (2016) · Immunotherapy · doi:10.2217/imt-2016-0020 · Cited by 708 · see citing works

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis

The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Domingo, P., Mur, I., Mateo, G. M., Gutierrez, M. D. M., Pomar, V., de Benito, N., Corbacho, N., Herrera, S., Millan, L., et al. (2021) · JAMA · doi:10.1001/jama.2021.11330 · Cited by 678 · see citing works

Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay

Matsushita, K., Takeuchi, O., Standley, D. M., Kumagai, Y., Kawagoe, T., Miyake, T., Satoh, T., Kato, H., Tsujimura, T., Nakamura, H., et al. (2009) · Nature · doi:10.1038/nature07924 · Cited by 677 · see citing works

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

Gabay, C., Emery, P., van Vollenhoven, R., Dikranian, A., Alten, R., Pavelka, K., Klearman, M., Musselman, D., Agarwal, S., Green, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60250-0 · Cited by 672 · see citing works

Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder

Yamamura, T., Kleiter, I., Fujihara, K., Palace, J. A., Greenberg, B. M., Zakrzewska‐Pniewska, B., Patti, F., Tsai, C., Saiz, A., Yamazaki, H., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1901747 · Cited by 663 · see citing works

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8)

Winkler, U., Jensen, M., Manzke, O., Schulz, H., Diehl, V., & Engert, A. (1999) · Blood · doi:10.1182/blood.v94.7.2217.419k02_2217_2224 · Cited by 657 · see citing works

Interleukin-6: designing specific therapeutics for a complex cytokine

Garbers, C., Heink, S., Korn, T., & Rose-John, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.45 · Cited by 643 · see citing works

Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy

Teachey, D. T., Rheingold, S. R., Maude, S. L., Zugmaier, G., Barrett, D. M., Seif, A. E., Nichols, K. E., Suppa, E. K., Kalos, M., Berg, R. A., et al. (2013) · Blood · doi:10.1182/blood-2013-02-485623 · Cited by 613 · see citing works

The origins, function, and regulation of T follicular helper cells

Ma, C. S., Deenick, E. K., Batten, M., & Tangye, S. G. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20120994 · Cited by 550 · see citing works

IL‐6 and NF‐IL6 in Acute‐Phase Response and Viral Infection

Akira, S., & Kishimoto, T. (1992) · Immunological Reviews · doi:10.1111/j.1600-065x.1992.tb01407.x · Cited by 531 · see citing works

Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial

Choy, E. H. S., Isenberg, D. A., Garrood, T., Farrow, S., Ioannou, Y., Bird, H., Cheung, N., Williams, B., Hazleman, B., Price, R., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10623 · Cited by 526 · see citing works

Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial

Traboulsee, A., Greenberg, B. M., Bennett, J. L., Szczechowski, L., Fox, E., Shkrobot, S., Yamamura, T., Terada, Y., Kawata, Y., Wright, P., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30078-8 · Cited by 513 · see citing works

Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis.

Guerne, P. A., Zuraw, B. L., Vaughan, J. H., Carson, D. A., & Lotz, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113921 · Cited by 512 · see citing works

Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19

Somers, E. C., Eschenauer, G. A., Troost, J. P., Golob, J. L., Gandhi, T. N., Wang, L., Zhou, N., Petty, L. A., Baang, J. H., Dillman, N. O., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa954 · Cited by 495 · see citing works

Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica

Chihara, N., Aranami, T., Sato, W., Miyazaki, Y., Miyake, S., Okamoto, T., Ogawa, M., Toda, T., & Yamamura, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017385108 · Cited by 476 · see citing works

Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages

Liao, W., Lin, J.-X., Wang, L., Li, P., & Leonard, W. J. (2011) · Nature Immunology · doi:10.1038/ni.2030 · Cited by 474 · see citing works

HTLV-I Tax Induces Cellular Proteins that Activate the κB Element in the IL-2 Receptor α Gene

Ballard, D. W., Böhnlein, E., Lowenthal, J. W., Wano, Y., Franza, B. R., & Greene, W. C. (1988) · Science · doi:10.1126/science.2843985 · Cited by 468 · see citing works

Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells.

Jirik, F. R., Podor, T. J., Hirano, T., Kishimoto, T., Loskutoff, D. J., Carson, D. A., & Lotz, M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.1.144 · Cited by 458 · see citing works

A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors

Kaur, S., Bansal, Y., Kumar, R., & Bansal, G. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115327 · Cited by 454 · see citing works

Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy

Nishimoto, N., Sasai, M., Shima, Y., Nakagawa, M., Matsumoto, T., Shirai, T., Kishimoto, T., & Yoshizaki, K. (2000) · Blood · doi:10.1182/blood.v95.1.56.001k13_56_61 · Cited by 445 · see citing works

Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130

Narazaki, M., Yasukawa, K., Saito, T., Ohsugi, Y., Fukui, H., Koishihara, Y., Yancopoulos, G. D., Taga, T., & Kishimoto, T. (1993) · Blood · doi:10.1182/blood.v82.4.1120.bloodjournal8241120 · Cited by 431 · see citing works

AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance

Jarius, S., & Wildemann, B. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.72 · Cited by 424 · see citing works

Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals

Harwood, C. A., Surentheran, T., McGregor, J., Spink, P. J., Leigh, I. M., Breuer, J., & Proby, C. M. (2000) · Journal of Medical Virology · doi:10.1002/1096-9071(200007)61:3 · Cited by 423 · see citing works

Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses

Kimura, A., Naka, T., Nakahama, T., Chinen, I., Masuda, K., Nohara, K., Fujii‐Kuriyama, Y., & Kishimoto, T. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090560 · Cited by 414 · see citing works

Interleukin 6 plays a key role in the development of antigen-induced arthritis

Ohshima, S., Saeki, Y., Mima, T., Sasai, M., Nishioka, K., Nomura, S., Kopf, M., Katada, Y., Tanaka, T., Suemura, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8222 · Cited by 406 · see citing works

Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells

Heink, S., Yogev, N., Garbers, C., Herwerth, M., Aly, L., Gasperi, C., Husterer, V., Croxford, A. L., Möller‐Hackbarth, K., Bartsch, H. S., et al. (2016) · Nature Immunology · doi:10.1038/ni.3632 · Cited by 401 · see citing works

Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor

Lust, J. A., Donovan, K. A., Kline, M. P., Greipp, P. R., Kyle, R. A., & Maihle, N. J. (1992) · Cytokine · doi:10.1016/1043-4666(92)90043-q · Cited by 395 · see citing works

Anti–interleukin‐6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis

Nakahara, H., Song, J., Sugimoto, M., Hagihara, K., Kishimoto, T., Yoshizaki, K., & Nishimoto, N. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11143 · Cited by 391 · see citing works

Regnase-1 and Roquin Regulate a Common Element in Inflammatory mRNAs by Spatiotemporally Distinct Mechanisms

Mino, T., Murakawa, Y., Fukao, A., Vandenbon, A., Wessels, H.-H., Ori, D., Uehata, T., Tartey, S., Akira, S., Suzuki, Y., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.029 · Cited by 390 · see citing works

Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)

Nakaoka, Y., Isobe, M., Takei, S., Tanaka, Y., Ishii, T., Yokota, S., Nomura, A., Yoshida, S., & Nishimoto, N. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211878 · Cited by 386 · see citing works

Identification of IL6R and chromosome 11q13.5 as risk loci for asthma

Ferreira, M. A., Matheson, M. C., Duffy, D. L., Marks, G. B., Hui, J., Le Souëf, P., Danoy, P., Baltic, S., Nyholt, D. R., Jenkins, M., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60874-x · Cited by 381 · see citing works

Therapeutic efficacy of humanized recombinant anti–interleukin‐6 receptor antibody in children with systemic‐onset juvenile idiopathic arthritis

Yokota, S., Miyamae, T., Imagawa, T., Iwata, N., Katakura, S., Mori, M., Woo, P. M., Nishimoto, N., Yoshizaki, K., & Kishimoto, T. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20944 · Cited by 370 · see citing works

Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome

Kreins, A. Y., Ciancanelli, M. J., Okada, S., Kong, X., Ramirez‐Alejo, N., Kılıç, S. Ş., Baghdadi, J. E., Nonoyama, S., Mahdaviani, S. A., Ailal, F., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20140280 · Cited by 364 · see citing works

IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells.

Okada, M., Kitahara, M., Kishimoto, S., Matsuda, T., Hirano, T., & Kishimoto, T. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.5.1543 · Cited by 360 · see citing works

Factors Affecting B-Cell Growth and Differentiation

Kishimoto, T. (1985) · Annual Review of Immunology · doi:10.1146/annurev.iy.03.040185.001025 · Cited by 360 · see citing works

Historical overview of the interleukin-6 family cytokine

Kang, S., Narazaki, M., Metwally, H., & Kishimoto, T. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190347 · Cited by 360 · see citing works

Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock

Pathan, N., Hemingway, C. A., Alizadeh, A. A., Stephens, A. C., Boldrick, J. C., Oragui, E. E., McCabe, C., Welch, S. B., Whitney, A. R., O’Gara, P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15326-3 · Cited by 358 · see citing works

Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.

Brandt, S. J., Bodine, D., Dunbar, C., & Nienhuis, A. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114749 · Cited by 345 · see citing works

IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF- and IL-17

Hashizume, M., Hayakawa, N., & Mihara, M. (2008) · Rheumatology · doi:10.1093/rheumatology/ken363 · Cited by 345 · see citing works

Late Interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection

Harker, J., Lewis, G. M., Mack, L. A., & Zuniga, E. (2011) · Science · doi:10.1126/science.1208421 · Cited by 341 · see citing works

Protective Effects of IL-6 Blockade in Sepsis Are Linked to Reduced C5a Receptor Expression1

Riedemann, N., Neff, T., Guo, R., Bernacki, K. D., Laudes, I. J., Sarma, J., Lambris, J. D., & Ward, P. A. (2003) · Journal of Immunology · doi:10.4049/jimmunol.170.1.503 · Cited by 340 · see citing works

IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome

Kang, S., Tanaka, T., Inoue, H., Ono, C., Hashimoto, S., Kioi, Y., Matsumoto, H., Matsuura, H., Matsubara, T., Shimizu, K., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010229117 · Cited by 328 · see citing works

The bath ankylosing spondylitis radiology index (BASRI): A new, validated approach to disease assessment

Mackay, K., Mack, C., Brophy, S. T., & Călin, A. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12 · Cited by 327 · see citing works

Yes-Associated Protein Up-regulates Jagged-1 and Activates the NOTCH Pathway in Human Hepatocellular Carcinoma

Tschaharganeh, D. F., Chen, X., Latzko, P., Malz, M., Gaida, M. M., Felix, K., Ladu, S., Singer, S., Pinna, F., Gretz, N., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.009 · Cited by 326 · see citing works

Impaired skeletal development in interleukin‐6–transgenic mice: A model for the impact of chronic inflammation on the growing skeletal system

Benedetti, F. D., Rucci, N., Fattore, A. D., Peruzzi, B., Paro, R., Longo, M., Vivarelli, M., Muratori, F. M., Berni, S., Ballanti, P., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22175 · Cited by 320 · see citing works

Inflammatory Skin and Bowel Disease Linked toADAM17Deletion

Blaydon, D. C., Biancheri, P., Di, W., Plagnol, V., Cabral, R. M., Brooke, M. A., van Heel, D. A., Rüschendorf, F., Toynbee, M., Walne, A. J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100721 · Cited by 307 · see citing works

Efficacy of the anti–IL-6 receptor antibody tocilizumab in neuromyelitis optica

Araki, M., Matsuoka, T., Miyamoto, K., Kusunoki, S., Okamoto, T., Murata, M., Miyake, S., Aranami, T., & Yamamura, T. (2014) · Neurology · doi:10.1212/wnl.0000000000000317 · Cited by 306 · see citing works

Genomic structure of the murine IL-6 gene. High degree conservation of potential regulatory sequences between mouse and human.

Tanabe, O., Akira, S., Kamiya, T., Wong, G. G., Hirano, T., & Kishimoto, T. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.11.3875 · Cited by 292 · see citing works

The IκB kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR–IL-1R by controlling degradation of regnase-1

Iwasaki, H., Takeuchi, O., Teraguchi, S., Matsushita, K., Uehata, T., Kuniyoshi, K., Satoh, T., Saitoh, T., Matsushita, M., Standley, D. M., et al. (2011) · Nature Immunology · doi:10.1038/ni.2137 · Cited by 288 · see citing works

Clinical aspects of systemic amyloid diseases

Obici, L. P., Perfetti, V., Palladini, G. O., Moratti, R., & Merlini, G. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.08.014 · Cited by 277 · see citing works

Adult-onset Still disease

Fautrel, B. (2008) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2008.08.006 · Cited by 276 · see citing works

Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study

Biran, N., Ip, A., Ahn, J., Go, R. C., Wang, S., Mathura, S., Sinclaire, B., Bednarz, U., Marafelias, M., Hansen, E., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30277-0 · Cited by 274 · see citing works

Juvenile idiopathic arthritis.

Ravelli, A., & Martini, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60363-8 · Cited by 252 · see citing works

Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study

Genovese, M., Fleischmann, R., Kivitz, A., Rell-Bakalarska, M., Martinčová, R., Fiore, S., Rohane, P., van Hoogstraten, H. V., Garg, A., Fan, C., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39093 · Cited by 244 · see citing works

The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.

Scala, G., Ruocco, M. R., Ambrosino, C., Mallardo, M., Giordano, V., Baldassarre, F., Dragonetti, E., Quinto, I., & Venuta, S. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.3.961 · Cited by 242 · see citing works

Interleukin-6 and RANTES in Takayasu Arteritis

Noris, M., Daina, E., Gamba, S., Bonazzola, S., & Remuzzi, G. (1999) · Circulation · doi:10.1161/01.cir.100.1.55 · Cited by 236 · see citing works

Interleukin-6 Causes Endothelial Barrier Dysfunction via the Protein Kinase C Pathway

Desai, T. R., Leeper, N. J., Hynes, K. L., & Gewertz, B. L. (2002) · Journal of Surgical Research · doi:10.1006/jsre.2002.6415 · Cited by 235 · see citing works

IL-6-regulated transcription factors

Akira, S. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00063-0 · Cited by 231 · see citing works

The IL-6-Soluble IL-6Rα Autocrine Loop of Endothelial Activation as an Intermediate Between Acute and Chronic Inflammation: an Experimental Model Involving Thrombin

Marin, V., Montero-Julian, F., Grès, S., Boulay, V., Bongrand, P., Farnarier, C., & Kaplanski, G. (2001) · Journal of Immunology · doi:10.4049/jimmunol.167.6.3435 · Cited by 227 · see citing works

Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo

Masuda, K., Ripley, B., Nishimura, R., Mino, T., Takeuchi, O., Shioi, G., Kiyonari, H., & Kishimoto, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307419110 · Cited by 226 · see citing works

Anti-interleukin 6 receptor antibody treatment in rheumatic disease

Nishimoto, N., Kishimoto, T., & Yoshizaki, K. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.suppl_1.i21 · Cited by 214 · see citing works

High serum interleukin‐6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B

Wong, V. W., Yu, J. Q., Cheng, A. S. L., Wong, G. L., Chan, H., Chu, E. S., Ng, E. K. O., Chan, F. K. L., Sung, J. J. �., & Chan, H. L. (2009) · International Journal of Cancer · doi:10.1002/ijc.24281 · Cited by 208 · see citing works

Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses

Spencer, S., Bal, S. K., Egner, W., Allen, H. L., Raza, S. I., Ma, C. A., Gürel, M., Zhang, Y., Sun, G., Sabroe, R. A., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190344 · Cited by 206 · see citing works

Structure‐function analysis of human IL‐6 receptor: dissociation of amino acid residues required for IL‐6‐binding and for IL‐6 signal transduction through gp130.

Yawata, H., Yasukawa, K., Natsuka, S., Murakami, M., Yamasaki, K., Hibi, M., Taga, T., & Kishimoto, T. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05815.x · Cited by 205 · see citing works

A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis

Schwerd, T., Twigg, S. R. F., Aschenbrenner, D., Manrique, S., Miller, K. A., Taylor, I. B., Capitani, M., McGowan, S. J., Sweeney, E. A., Weber, A. P., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161810 · Cited by 204 · see citing works

MicroRNA-155 Regulates Inflammatory Cytokine Production in Tumor-associated Macrophages via Targeting C/EBPβ

He, M. Y., Xu, Z., Ding, T., Kuang, D., & Zheng, L. (2009) · Cellular and Molecular Immunology · doi:10.1038/cmi.2009.45 · Cited by 199 · see citing works

Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial

Kaneko, Y., Kameda, H., Ikeda, K., Ishii, T., Murakami, K., Takamatsu, H., Tanaka, Y., Abe, T., & Takeuchi, T. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213920 · Cited by 192 · see citing works

Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.

Müller-Newen, G., Küster, A., Hemmann, U., Keul, R., Horsten, U., Martens, A. S., Graeve, L., Wijdenes, J., & Heinrich, P. (1998) · Journal of Immunology · doi:10.4049/jimmunol.161.11.6347 · Cited by 186 · see citing works

Expression and Function of C5a Receptor in Mouse Microvascular Endothelial Cells

Laudes, I. J., Chu, J. C., Huber-Lang, M. S., Guo, R., Riedemann, N. C., Sarma, J. V., Mahdi, F., Murphy, H. S., Speyer, C. L., Lu, K. T., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5962 · Cited by 181 · see citing works

Therapeutic uses of anti-interleukin-6 receptor antibody

Kang, S., Tanaka, T., & Kishimoto, T. (2014) · International Immunology · doi:10.1093/intimm/dxu081 · Cited by 172 · see citing works

Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis

DASGUPTA, B., & PANAYI, G. S. (1990) · Rheumatology · doi:10.1093/rheumatology/29.6.456 · Cited by 171 · see citing works

Hepatic cytochrome P450 down‐regulation during aseptic inflammation in the mouse is interleukin 6 dependent

Siewert, E., Bort, R., Kluge, R., Heinrich, P. C., Castell, J., & Jover, R. (2000) · Hepatology · doi:10.1053/jhep.2000.8532 · Cited by 170 · see citing works

The soluble interleukin 6 receptor: advanced therapeutic options in inflammation

Rose‐John, S. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.782 · Cited by 169 · see citing works

The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases

Garbers, C., Monhasery, N., Aparicio-Siegmund, S., Lokau, J., Baran, P., Nowell, M. A., Jones, S. A., Rose-John, S., & Scheller, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.018 · Cited by 155 · see citing works

Circulating markers of angiogenesis and endotheliopathy in COVID‐19

Pine, A. B., Meizlish, M. L., Goshua, G., Chang, C., Zhang, H., Bishai, J. D., Bahel, P., Patel, A. J., Gbyli, R., Kwan, J. M., et al. (2020) · Pulmonary Circulation · doi:10.1177/2045894020966547 · Cited by 150 · see citing works

Cytokine release syndrome associated with chimeric-antigen receptor T-cell therapy: clinicopathological insights

Obstfeld, A. E., Frey, N. V., Mansfield, K. G., Lacey, S. F., June, C. H., Porter, D. L., Melenhorst, J. J., & Wasik, M. A. (2017) · Blood · doi:10.1182/blood-2017-08-802413 · Cited by 133 · see citing works

Aryl hydrocarbon receptor deficiency in T cells suppresses the development of collagen-induced arthritis

Nakahama, T., Kimura, A., Nguyen, N. T., Chinen, I., Hanieh, H., Nohara, K., Fujii‐Kuriyama, Y., & Kishimoto, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111786108 · Cited by 132 · see citing works

HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice.

Suthaus, J., Stuhlmann-Laeisz, C., Tompkins, V., Rosean, T. R., Klapper, W., Tosato, G., Janz, S., Scheller, J., & Rose-John, S. (2012) · Blood · doi:10.1182/blood-2011-09-377705 · Cited by 131 · see citing works

Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration

Peters, M., Blinn, G., Jostock, T., Schirmacher, P., Büschenfelde, K. M. Z., Galle, P. R., & Rose–John, S. (2000) · Gastroenterology · doi:10.1053/gast.2000.20236 · Cited by 129 · see citing works

A novel mechanism of neutrophil recruitment in a coculture model of the rheumatoid synovium

Lally, F., Smith, E., Filer, A. D., Stone, M., Shaw, J. S., Nash, G. B., Buckley, C. D., & Rainger, G. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21394 · Cited by 128 · see citing works

Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity?

van der Stegen, S. J. C., Davies, D. M., Wilkie, S., Foster, J., Sosabowski, J. K., Burnet, J., Whilding, L. M., Petrovic, R. M., Ghaem-Maghami, S., Mather, S., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301523 · Cited by 126 · see citing works

MiR-26 down-regulates TNF-α/NF-κB signalling and IL-6 expression by silencing HMGA1 and MALT1

Chen, C. A., Chang, J. T., Ho, Y.-F., & Shyu, A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw205 · Cited by 104 · see citing works

The IL6R variation Asp358Ala is a potential modifier of lung function in subjects with asthma

Hawkins, G. A., Robinson, M., Hastie, A. T., Li, X., Li, H., Moore, W. C., Howard, T. D., Busse, W. W., ERZURUM, S. C., Wenzel, S. E., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.03.018 · Cited by 98 · see citing works

Arid5a regulates naive CD4+ T cell fate through selective stabilization of Stat3 mRNA

Masuda, K., Ripley, B., Nyati, K. K., Dubey, P. K., Zaman, M. M.-U., Hanieh, H., Higa, M., Yamashita, K., Standley, D. M., Mashima, T., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151289 · Cited by 95 · see citing works

Gab-Family Adapter Molecules in Signal Transduction of Cytokine and Growth Factor Receptors, and T and B Cell Antigen Receptors

Hibi, M., & Hirano, T. (2000) · Leukemia and Lymphoma · doi:10.3109/10428190009089430 · Cited by 94 · see citing works

YAP–IL-6ST autoregulatory loop activated on APC loss controls colonic tumorigenesis

Taniguchi, K., Moroishi, T., de Jong, P., Krawczyk, M., Grebbin, B. M., Luo, H.-Y., Xu, R.-H., Golob-Schwarzl, N., Schweiger, C., Wang, K.-P., et al. (2017) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1620290114 · Cited by 89 · see citing works

Regulation of Antibody Response in Vitro

Kishimoto, T., & Ishizaka, K. (1973) · The Journal of Immunology · doi:10.4049/jimmunol.111.4.1194 · Cited by 83 · see citing works

Catch‐Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial

Benedetti, F. D., Brunner, H. I., Ruperto, N., Schneider, R., Xavier, R. M., Allen, R. C., Brown, D. E., Chaitow, J., Pardeo, M., Espada, G., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38984 · Cited by 81 · see citing works

Soluble gp130 prevents interleukin-6 and interleukin-11 cluster signaling but not intracellular autocrine responses

Lamertz, L., Rummel, F., Polz, R., Baran, P., Hansen, S., Waetzig, G. H., Moll, J. M., Floss, D. M., & Scheller, J. (2018) · Science Signaling · doi:10.1126/scisignal.aar7388 · Cited by 81 · see citing works

In Vitro Immune Response of Human Peripheral Lymphocytes

Hirano, T., Kuritani, T., Kishimoto, T., & Yamamura, Y. (1977) · The Journal of Immunology · doi:10.4049/jimmunol.119.4.1235 · Cited by 76 · see citing works

Modification of the anti‐CD3‐induced cytokine release syndrome by anti‐interferon‐γ or anti‐interleukin‐6 antibody treatment: Protective effects and biphasic changes in blood cytokine levels

Matthys, P., Dillen, C., Proost, P., Heremans, H., Damme, J. V., & Billiau, A. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230924 · Cited by 69 · see citing works

Post-transcriptional regulation of immune responses by RNA binding proteins

Mino, T., & Takeuchi, O. (2018) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.94.017 · Cited by 67 · see citing works

Regulation of Antibody Response in Vitro

Kishimoto, T., & Ishizaka, K. (1973) · The Journal of Immunology · doi:10.4049/jimmunol.111.3.720 · Cited by 67 · see citing works

Association of interleukin-6 gene polymorphism with coronary artery disease: an updated systematic review and cumulative meta-analysis

Hou, H., Wang, C., Sun, F., Zhao, L., Dun, A., & Sun, Z. (2015) · Inflammation Research · doi:10.1007/s00011-015-0850-9 · Cited by 55 · see citing works

Regulation of the Interleukin-6 gene expression during monocytic differentiation of HL-60 cells by chromatin remodeling and methylation

Poplutz, M. K., Weßels, I., Rink, L., & Uciechowski, P. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.03.016 · Cited by 52 · see citing works

The IL-6-neutralizing sIL-6R/sgp130 buffer system is disturbed in patients with type 2 diabetes.

Aparicio-Siegmund, S., Garbers, Y., Flynn, C. M., Waetzig, G. H., Gouni-Berthold, I., Krone, W., Berthold, H., Laudes, M., Rose-John, S., & Garbers, C. (2019) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.00166.2019 · Cited by 45 · see citing works

The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis

Hein, G. E., Köhler, M. M., Oelzner, P., Stein, G., & Franke, S. (2004) · Rheumatology International · doi:10.1007/s00296-004-0518-1 · Cited by 45 · see citing works

AT‐Rich–Interactive Domain–Containing Protein 5A Functions as a Negative Regulator of Retinoic Acid Receptor–Related Orphan Nuclear Receptor γt–Induced Th17 Cell Differentiation

Saito, Y., Kagami, S., Sanayama, Y., Ikeda, K., Suto, A., Kashiwakuma, D., Furuta, S., Iwamoto, I., Nonaka, K., Ohara, O., et al. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38324 · Cited by 40 · see citing works

CD40 promotion of amyloid beta production occurs via the NF‐κB pathway

Ait‐Ghezala, G., Volmar, C., Frieling, J. S., Paris, D., Tweed, M., Bakshi, P., & MULLAN, M. J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05424.x · Cited by 24 · see citing works

Regulation of Antibody Response in Vitro

Kishimoto, T., & Ishizaka, K. (1973) · The Journal of Immunology · doi:10.4049/jimmunol.111.1.1 · Cited by 24 · see citing works

Effect of Tocilizumab on growth impairment in systemic juvenile idiopathic arthritis with long-term corticosteroid therapy

Miyamae, T., Yokoya, S., Yamanaka, H., & Yokota, S. (2013) · Modern Rheumatology · doi:10.3109/14397595.2013.844404 · Cited by 14 · see citing works

Inotropic Effects of Calcium Antagonists in the Cardiomyopathic Syrian Hamster

Finkel, M. S., Romeo, R. C., Oddis, C. V., & Salama, G. (1992) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199204000-00011 · Cited by 14 · see citing works

Targeting IL-6 trans-signalling: past, present and future prospects

Rose-John, S., Jenkins, B. J., Garbers, C., Moll, J. M., & Scheller, J. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00856-y · Cited by 524 · see citing works

Targeting cytokine and chemokine signaling pathways for cancer therapy

Yi, M., Li, T., Niu, M., Zhang, H., Wu, Y., Wu, K., & Dai, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01868-3 · Cited by 491 · see citing works

Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach

Aliyu, M., Zohora, F. T., Anka, A. U., Ali, K., Maleknia, S., Saffarioun, M., & Azizi, G. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109130 · Cited by 433 · see citing works

The advent of immune stimulating CAFs in cancer

Tsoumakidou, M. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00549-7 · Cited by 189 · see citing works

Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms

Wu, Y., Sun, X., Kang, K., Yang, Y., Li, H., Zhao, A., & Niu, T. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01621-x · Cited by 113 · see citing works

The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases

Wang, M.-J., Zhang, H.-L., Chen, F., Guo, X.-J., Liu, Q.-G., & Hou, J. (2024) · Experimental Hematology & Oncology · doi:10.1186/s40164-024-00527-1 · Cited by 84 · see citing works

Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis

García, A. G., Fernández-Martín, J., & Marhuenda, Á. R. (2022) · Rheumatology · doi:10.1093/rheumatology/keac481 · Cited by 63 · see citing works

Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19

Matsumoto, C., Shibata, S., Kishi, T., Morimoto, S., Mogi, M., Yamamoto, K. I., Kobayashi, K., Tanaka, M., Asayama, K., Yamamoto, E., et al. (2022) · Hypertension Research · doi:10.1038/s41440-022-01145-2 · Cited by 59 · see citing works

Anti‐Acidification and Immune Regulation by Nano‐Ceria‐Loaded Mg–Al Layered Double Hydroxide for Rheumatoid Arthritis Therapy

Fu, H., Guo, Y., Fang, W., Wang, J., Hu, P., & Shi, J. (2023) · Advanced Science · doi:10.1002/advs.202307094 · Cited by 54 · see citing works

Central Roles of STAT3-Mediated Signals in Onset and Development of Cancers: Tumorigenesis and Immunosurveillance

Hashimoto, S., Hashimoto, A., Muromoto, R., Kitai, Y., Oritani, K., & Matsuda, T. (2022) · Cells · doi:10.3390/cells11162618 · Cited by 50 · see citing works

Roles of RNA-binding proteins in immune diseases and cancer

Hashimoto, S., & Kishimoto, T. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.017 · Cited by 49 · see citing works

A single infusion of engineered long-lived and multifunctional T cells confers durable remission of asthma in mice

Jin, G., Liu, Y., Wang, L., He, Z., Zhao, X., Ma, Y., Jia, Y., Li, Z., Yin, N., & Peng, M. (2024) · Nature Immunology · doi:10.1038/s41590-024-01834-9 · Cited by 51 · see citing works

Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs

Swaroop, A. K., Negi, P., Kar, A., Mariappan, E., Natarajan, J., Namboori, P. K. K., & Selvaraj, J. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.12.007 · Cited by 48 · see citing works

Structure of the IL-27 quaternary receptor signaling complex

(2022) · doi:10.7554/elife.78463 · Cited by 44 · see citing works

Osteoarthritis: molecular pathogenesis and potential therapeutic options

Zhang, Y., Han, Y.-Q., Sun, Y., Hao, L.-H., Gao, Y., Ye, J., Wang, H.-L., Zhang, T.-T., Liu, Y.-L., & Yang, Y.-F. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02556-6 · Cited by 24 · see citing works

N-linked glycosylation of PD-L1/PD-1: an emerging target for cancer diagnosis and treatment

Duan, Z., Shi, R.-H., Gao, B., & Cai, J. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05502-2 · Cited by 45 · see citing works

IL-6 Signaling in Immunopathology: From Basic Biology to Selective Therapeutic Intervention

Schumertl, T., Lokau, J., & Garbers, C. (2025) · ImmunoTargets and Therapy · doi:10.2147/itt.s485684 · Cited by 40 · see citing works

Perspectives of JAK Inhibitors for Large Vessel Vasculitis

Watanabe, R., & Hashimoto, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.881705 · Cited by 36 · see citing works

Association between premature vascular smooth muscle cells senescence and vascular inflammation in Takayasu's arteritis

Fang, C., Du, L., Gao, S., Chen, Y., Chen, Z., Wu, Z., Li, L., Li, J., Zeng, X., Li, M., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2024-225630 · Cited by 30 · see citing works

Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies

Chasov, V. V., Zmievskaya, E., Ganeeva, I., Gilyazova, E., Davletshin, D., Khaliulin, M., Kabwe, E., Davidyuk, Y. N., Valiullina, A., Rizvanov, A. A., et al. (2024) · Antibodies · doi:10.3390/antib13010010 · Cited by 29 · see citing works

Structural insights into IL-6 signaling inhibition by therapeutic antibodies

Wang, M., Chen, L., He, J., Xia, W., Ye, Z., & She, J. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113819 · Cited by 29 · see citing works

Roles of Interleukin-6-mediated immunometabolic reprogramming in COVID-19 and other viral infection-associated diseases

Li, Y., Ren, H.-C., & Cao, J.-H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109005 · Cited by 33 · see citing works

Pathogenic role of monocytes/macrophages in large vessel vasculitis

Watanabe, R., & Hashimoto, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.859502 · Cited by 27 · see citing works

Characterization of the Biological Activity of the Ethanolic Extract from the Roots of Cannabis sativa L. Grown in Aeroponics

Ferrini, F., Zeppa, S. D., Fraternale, D., Carrabs, V., Annibalini, G., Verardo, G., Gorassini, A., Albertini, M. C., Ismail, T., Fimognari, C., et al. (2022) · Antioxidants · doi:10.3390/antiox11050860 · Cited by 25 · see citing works

Roles of inflammasomes in viral myocarditis

Xu, J., Zhou, Z., Zheng, Y., Yang, S., Huang, K., & Li, H. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1149911 · Cited by 24 · see citing works

CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma

Li, H., Song, W., Wu, J., Shi, Z., Gao, Y., Li, J. Y., Han, L., Zhang, J., Li, Z., Li, Y., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-03040-0 · Cited by 23 · see citing works

The prospects of interleukin-6 inhibition in rheumatoid arthritis: Olokizumab (novel monoclonal antibodies to IL-6)

Nasonov, E. L., & Feist, E. (2022) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2022-505-518 · Cited by 21 · see citing works

Monocyte/macrophage-mediated venous thrombus resolution

Lü, M.-J., Zhang, J., Nie, Z.-Y., Yan, T., Cao, Y., Zhang, L., & Li, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1429523 · Cited by 20 · see citing works

Vasculitogenic T Cells in Large Vessel Vasculitis

Watanabe, R., & Hashimoto, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.923582 · Cited by 22 · see citing works

Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis

Chen, R., Shi, Y., Fang, N., Shao, C., Huang, H. F., Pan, R., Xu, Y., Wang, M., Liu, X., Xu, K. L., et al. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03834-y · Cited by 18 · see citing works

Exploring the mechanism of Celastrol in the treatment of rheumatoid arthritis based on systems pharmacology and multi-omics

Zeng, L., Yu, G., Yang, K., He, Q., Hao, W., Wang, X., Long, Z., Chen, H., Tang, X., & Sun, L. (2024) · Scientific Reports · doi:10.1038/s41598-023-48248-5 · Cited by 18 · see citing works

Drugs targeting CMPK2 inhibit pyroptosis to alleviate severe pneumonia caused by multiple respiratory viruses

Tang, Z., Mao, Y., Ruan, P., Li, J., Qiu, X., Meng, Y., Wang, M., Wu, G., Wang, L., & Tan, Y. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29643 · Cited by 18 · see citing works

Fluorinated dendrimer-mediated miR-30a delivery regulates the inflammation of macrophages and mitigates the symptoms of rheumatoid arthritis

Xing, J., Jia, J., Zhang, H., Han, H., & Li, Q. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.11.009 · Cited by 18 · see citing works

Gp130–HIF1α axis–induced vascular damage is prevented by the short-term inhibition of IL-6 receptor signaling

Kang, S., Onishi, S., Ling, Z., Inoue, H., Zhang, Y., Chang, H., Zhao, H., Wang, T., Okuzaki, D., Matsuura, H., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2315898120 · Cited by 17 · see citing works

Association between tocilizumab treatment of hyperinflammatory patients with COVID-19 in a critical care setting and elevated incidence of hospital-acquired bacterial and invasive fungal infections

Minihan, B., McAuliffe, É., Powell, J., Wong, S. L., Wilkie, K., Murphy, C., Maher, A., Power, L. E., O’Connell, N. H., & Dunne, C. P. (2022) · Journal of Hospital Infection · doi:10.1016/j.jhin.2022.04.007 · Cited by 17 · see citing works

Ultrasound-triggered piezocatalytic MOF(Hf)-Pt nanozymes for efficient ROS scavenging in the treatment of osteoarthritis

Yao, Y., Gao, Z., Pan, Z., Zhong, Y., Qin, L., Zhao, K., Liu, S., Zhang, S., Han, H., Yin, F., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.167229 · Cited by 16 · see citing works

Improving the safety of CAR‐T‐cell therapy: The risk and prevention of viral infection for patients with relapsed or refractory B‐cell lymphoma undergoing CAR‐T‐cell therapy

Qian, H., Yang, X., Zhang, T.-T., Zou, P., Zhang, Y., Tian, W., Mao, Z., & Wei, J. (2024) · American Journal of Hematology · doi:10.1002/ajh.27198 · Cited by 15 · see citing works

The new era of immunological treatment, last updated and future consideration of CAR T cell-based drugs.

Hadiloo, K., Taremi, S., Safa, S. H., Amidifar, S., & Esmaeilzadeh, A. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107158 · Cited by 11 · see citing works

Human retinal endothelial cells express functional interleukin-6 receptor

Ferreira, L. B., Ashander, L. M., Appukuttan, B., Ma, Y., Williams, K. A., Best, G., & Smith, J. R. (2023) · Journal of Ophthalmic Inflammation and Infection · doi:10.1186/s12348-023-00341-6 · Cited by 14 · see citing works

Amelioration of inflammation through reduction of oxidative stress in rheumatoid arthritis by treating fibroblast-like synoviocytes (FLS) with DMF-loaded PLGA nanoparticles

Royaei, M. R., Tahoori, M. T., Bardania, H., Shams, A., & Dehghan, A. M. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111617 · Cited by 13 · see citing works

New bitongling regulates gut microbiota to predict angiogenesis in rheumatoid arthritis via the gut-joint axis: a deep neural network approach

Guan, Y., Zhao, X., Lü, Y., Zhang, Y., Lu, Y., & Wang, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1528865 · Cited by 13 · see citing works

Effect of fluvoxamine on plasma interleukin-6 in patients with major depressive disorder: a prospective follow-up study

Li, X., Yan, D., Liao, M., Zhang, L., Li, Z., Liu, B., Chen, Y., Zhang, Y., Liu, J., & Li, L. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1163754 · Cited by 12 · see citing works

The NQR Complex Regulates the Immunomodulatory Function of Bacteroides thetaiotaomicron

Engelhart, M. J., Glowacki, R. W. P., Till, J. M., Harding, C. V., Martens, E. C., & Ahern, P. P. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200892 · Cited by 12 · see citing works

Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects

Nasonov, E. L. (2024) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2024-32-54 · Cited by 12 · see citing works

Anemia in elderly rheumatoid arthritis patients: a cohort study

Sun, Z.-J., Shao, H., Liu, H., & Ma, L. (2023) · Archives of Medical Science · doi:10.5114/aoms/172443 · Cited by 12 · see citing works

Role of T cells and cytokines in the pathogenesis of rheumatoid arthritis

Anandan, M., & Narayanan, J. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102278 · Cited by 11 · see citing works

Interleukin 6 Inhibition in Rheumatoid Arthritis: Highlight on Olokizumab

Feist, E., & Nasonov, E. (2023) · Rheumatology · doi:10.17925/rmd.2023.2.1.17 · Cited by 4 · see citing works

Long-COVID-19: the persisting imprint of SARS-CoV-2 infections on the innate immune system

Boes, M. L., & Falter‐Braun, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01717-9 · Cited by 10 · see citing works

LC-MS-based rheumatoid arthritis serum metabolomics reveals the role of deoxyinosine in attenuating collagen-induced arthritis in mice

Xu, D., Tang, L., Wang, Y., Pan, J., & Su, C. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30903 · Cited by 10 · see citing works

Disrupting the RNA polymerase II transcription cycle through CDK7 inhibition ameliorates inflammatory arthritis

Chen, X., Shibu, G., Sokolsky, B. A., Soussana, T. N., Fisher, L., Deochand, D. K., Dacic, M., Mantel, I., Ramirez, D. C., Bell, R. D., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adq5091 · Cited by 10 · see citing works

Carnosol Alleviates Collagen‐Induced Arthritis by Inhibiting Th17‐Mediated Immunity and Favoring Suppressive Activity of Regulatory T Cells

Chen, J., Sun, N., Li, F., Li, H., Tian, J., Zheng, S., Zhang, L., Wang, H., & Luo, Y. (2023) · BioMed Research International · doi:10.1155/2023/1179973 · Cited by 10 · see citing works

The latest advances in the use of biological DMARDs to treat Still’s disease

Cola, I. D., & Ruscitti, P. (2024) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2024.2307340 · Cited by 10 · see citing works

Preventing Preterm Birth

Habelrih, T., Ferri, B., Côté, F., Sévigny, J., Augustin, T.-L., Sawaya, K., Lubell, W. D., Olson, D. M., Girard, S., & Chemtob, S. (2024) · Clinics in Perinatology · doi:10.1016/j.clp.2024.02.006 · Cited by 10 · see citing works

Tissue-Resident Memory T Cells in Rheumatoid Immune Diseases: Pathogenic Mechanisms and Therapeutic Strategies

Tian, Y., Zhang, J., Wu, L., Zhang, C., Zheng, F., Yang, Y., Lu, G., & Xie, D. (2025) · Biomedicines · doi:10.3390/biomedicines13122945 · Cited by 9 · see citing works

Orchestration of mesenchymal plasticity and immune evasiveness via rewiring of the metabolic program in pancreatic ductal adenocarcinoma

Hashimoto, A., Handa, H., Hata, S., & Hashimoto, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1005566 · Cited by 9 · see citing works

Development and validation of machine learning-based models for predicting healthcare-associated bacterial/fungal infections among COVID-19 inpatients: a retrospective cohort study

Wang, M., Li, W., Wang, H., & Song, P. (2024) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-024-01392-7 · Cited by 10 · see citing works

Serum GM-CSF level is a predictor of treatment response to tocilizumab in rheumatoid arthritis patients: a prospective observational cohort study

Su, J., Hu, W., Ding, Y., Zhang, P., Li, T.-F., Liu, S., & Xing, L. (2024) · Arthritis Research & Therapy · doi:10.1186/s13075-024-03373-y · Cited by 8 · see citing works

Association between vitamin B6 levels and rheumatoid arthritis: a two-sample Mendelian randomization study

Liu, Y., Wang, X., You, M. S., Zheng, M., Yu, M., & Leng, X. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1442214 · Cited by 8 · see citing works

Impact of NSAIDs corticosteroids DMARDs biologics and their comparisons with natural products in C-reactive proteins (CRP) linked cardiovascular disorders

Satapathy, T., Minj, A., & Verma, M. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01767-1 · Cited by 11 · see citing works

Associations of Rheumatoid Factor, Rheumatoid Arthritis, and Interleukin-6 Inhibitor with the Prognosis of Ischemic Stroke: a Prospective Multicenter Cohort Study and Mendelian Randomization Analysis

Jia, Y., Zhang, K., Shi, M., Guo, D., Yang, P., Bu, X., Chen, J., Wang, A., Xu, T., He, J., et al. (2023) · Translational Stroke Research · doi:10.1007/s12975-023-01161-5 · Cited by 8 · see citing works

Associations of inflammatory cytokines with palmoplantar pustulosis: a bidirectional Mendelian randomization study

Liu, C., Liu, X., Xin, H., & Li, X. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1387210 · Cited by 7 · see citing works

Determination of Heterogeneous Proteomic and Metabolomic Response in anti-TNF and anti-IL-6 Treatment of Patients with Rheumatoid Arthritis

Stepanov, A. A., Malsagova, K. A., Kopylov, A. T., Rudnev, V. R., Karateev, D. E., Markelova, E. I., Лучихина, Е. Л., Borisova, E. E., & Kaysheva, A. L. (2023) · Life · doi:10.3390/life13020596 · Cited by 7 · see citing works

Ferroptosis-Modulating Natural Products for Targeting Inflammation-Related Diseases: Challenges and Opportunities in Manipulating Redox Signaling

Liang, Y., Qiu, S., Zou, Y., Leung, E. L., & Luo, L. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0556 · Cited by 7 · see citing works

Unveiling novel insights into human IL-6 − IL-6R interaction sites through 3D computer-guided docking and systematic site mutagenesis

Li, K., Cai, J., Jiang, Z., Meng, Q., Zhao, M., Xiao, H. M., Chen, G., Qiao, C., Luo, L., Yu, J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-69429-w · Cited by 7 · see citing works

Advances in pharmacotherapy for immunoinflammatory rheumatic diseases in the 21st century

Nasonov, E. L. (2025) · Terapevticheskii arkhiv · doi:10.26442/00403660.2025.05.203213 · Cited by 6 · see citing works

Blood Inflammatory Markers and Cytokines in COVID‐19 Patients With Bacterial Coinfections

Bi, Q., Zhu, J., Zheng, J., Xu, Q., Chen, J., Zhang, L., & Mu, X. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.70105 · Cited by 6 · see citing works

Factors Associated with Mortality Among Severe Omicron Patients for COVID-19

Wu, S., Liao, G., Mao, J., Yan, H., Chen, J., & Peng, J. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s450504 · Cited by 6 · see citing works

A New IL-6-Inducing Mechanism in Cancer with New Therapeutic Possibilities

Håkansson, L., Dunér, P., Broströmer, E., Gustavsson, B. G., Wettergren, Y., Ghafouri, B., Håkansson, A., & Clinchy, B. (2024) · Cancers · doi:10.3390/cancers16213588 · Cited by 5 · see citing works

Exploration of a bioactive oligosaccharide fragment from Saposhnikoviae Radix polysaccharides: preparation, structural characterization, and immunomodulatory mechanism

Sun, M., Cui, Y., Ma, W., Cui, L., Liang, P., Liang, M., Song, J., Tu, G., Ma, B., Jiang, Y., et al. (2026) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2026.124975 · Cited by 5 · see citing works

Targeting PI3Kγ Pathway for Treating Dengue virus Infection

Santos, F. R. D. S., Valadão, D. F., Bambirra, J. L., Moreira, T. P., de Souza, C. D., Passos, I. B. S., Queiroz‐Junior, C. M., Fagundes, C. T., Teixeira, M. M., Costa, V. V., et al. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107060 · Cited by 5 · see citing works

A novel modulator of IL-6R prevents inflammation-induced preterm birth and improves newborn outcome

Côté, F., Prairie, É., Sierra, E. M., Quiniou, C., Habelrih, T., Xu, W., Ferri, B., Hou, X., Lahaie, I., Côté, N., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00257-9 · Cited by 5 · see citing works

Lymph node-inspired immunoregulatory hydrogel with siRNA delivery property for postoperative glioblastoma treatment

Wang, Z., Geng, H., Zhang, Y., Shao, Y., Li, D., Li, Z., Ma, Y., Zhang, Y., Xi, K., Xue, Z., et al. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.146343 · Cited by 5 · see citing works

Normal butanol fraction of Polygonum hydropiper L. flavonoids reduces inflammation caused by PCV2 infections in cell and mouse models

Wei, Y., Zhou, S., Zhao, W. H., Chen, Q., Wang, Q.-H., Yu, M., Wei, Y., & Hu, T. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1539448 · Cited by 4 · see citing works

RNA Binding Protein YTHDF2 Inhibits Synovial Fibroblast Inflammation and Bone Injury in Rheumatoid Arthritis by Reducing the mRNA Stability of IL ‐ 6R

Zhang, Y., Cao, X., Ma, X., Guo, Y., Zhang, T., Wu, L., Yang, Y., Hao, C., Liu, W., & Guo, J. (2025) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.70010 · Cited by 4 · see citing works

The role of interleukin-6 in diabetic retinal disease: pathophysiology and therapeutic targeting

Harlow, R. E. A., Rose‐John, S., Hašková, Z., Fauser, S., & Mesquida, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1805665 · Cited by 4 · see citing works

Analysis of potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression immunologic indicators

Fu, T., Liu, Y., Jia, H., Yao, L., Zhang, S., & Tian, F. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115098 · Cited by 4 · see citing works

Methyl 2-[3-(4-hydroxyphenyl)prop-2-enoylamino]-3-phenylpropanoate Is a Potent Cell-Permeable Anti-Cytokine Compound To Inhibit Inflammatory Cytokines in Monocyte/Macrophage-Like Cells

Park, J. B. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001830 · Cited by 4 · see citing works

Immune Training of the Interleukin 6 Gene in Airway Epithelial Cells is Central to Asthma Exacerbations

Lunding, L. P., Weckmann, M., Zissler, U. M., Jakwerth, C. A., Bodenstein‐Sgró, R., Webering, S., Vock, C., Ehlers, J. C., Ceballos, R. A. M. F., Nemani, S. S. P., et al. (2025) · Allergy · doi:10.1111/all.70070 · Cited by 3 · see citing works

Clinical efficacy of exercise in the treatment of post-COVID-19 syndrome: a systematic review and network meta-analysis

Du, S., Cui, Z., Xu, X., Liu, T., & Ye, J. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1656713 · Cited by 4 · see citing works

Epigenome-wide association study of circulating interleukin-6 connects DNA methylation to immunometabolic and inflammatory health

Sinke, L., van Dongen, J., Delerue, T., Wilson, R., Xia, Y., Beekman, M., Willemsen, G. A. H. M., Gieger, C., Herder, C., Köenig, W., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-09520-2 · Cited by 4 · see citing works

Laboratory features of effects of peloidotherapy and aromatherapy in patients with rheumatoid arthritis

Pantović, S., Roganović, M., Slavić, V., & Zvizdojevic, J. M. (2024) · International Journal of Biometeorology · doi:10.1007/s00484-024-02630-8 · Cited by 3 · see citing works

When idiopathic multicentric Castleman disease meets COVID-19: a multicenter retrospective study from China

Liu, Y., Yin, X., Xu, D., Lv, Y., Li, Z., Yang, M. H., Yao, Q., Jin, J., Huang, L., Meng, H., et al. (2024) · Therapeutic Advances in Hematology · doi:10.1177/20406207241229584 · Cited by 3 · see citing works

An Evaluation of Type 1 Interferon Related Genes in Male and Female-Matched, SARS-CoV-2 Infected Individuals Early in the COVID-19 Pandemic

Huecksteadt, T., Myers, E., Aamodt, S., Trivedi, S., & Warren, K. (2024) · Viruses · doi:10.3390/v16030472 · Cited by 3 · see citing works

Exploring the IL-21/IL-21R Signaling Pathway in Rheumatoid Arthritis: Implications for Synoviocyte Survival and Disease Progression

Chen, Q., Lin, S. J., Wang, S., Huang, X., Liang, L., Lu, J., Xie, T., & Cai, X. (2025) · Immunological Investigations · doi:10.1080/08820139.2025.2542200 · Cited by 3 · see citing works

Identification and characterization of putative enhancer regions that direct Il6 transcription in murine macrophages

Kano, N., Miki, T., Uehara, Y., Ori, D., & Kawai, T. (2024) · International Immunology · doi:10.1093/intimm/dxae024 · Cited by 2 · see citing works

The use of tocilizumab in severe COVID-19: A comprehensive review

Milošević, I., & Beronja, B. (2024) · Medicinska istrazivanja · doi:10.5937/medi57-48405 · Cited by 2 · see citing works

Early prediction and warning of MODS following major trauma via identification of cytokine storm: A prospective cohort study

Chang, P., Li, R., Wen, J., Liu, G., Jin, F., Yu, Y., Li, Y., Zhang, G., & Wang, T. (2025) · Chinese Journal of Traumatology · doi:10.1016/j.cjtee.2025.05.001 · Cited by 2 · see citing works

Targeting the Dynamics Between TAMs and CAR‐T Cells in Solid Tumor Therapies

Zhang, X., Zheng, H., Liu, Z.-C., Luo, L., Dong, X., Cui, X., Wu, Y., & Chen, L. (2025) · Advanced Science · doi:10.1002/advs.202515700 · Cited by 2 · see citing works

Orally Administered Self-Microemulsifying Celastrol Alleviates Rheumatoid Arthritis by Modulating the Expression of TNF-α

Ma, B., Li, Y., Zhang, J., Fu, Y., & Cao, H. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18060695 · Cited by 2 · see citing works

Early rheumatoid factor decline predicts subsequent clinical remission in rheumatoid arthritis: the ANSWER cohort

Sugimoto, K., Watanabe, R., Fujita, Y., Fujii, T., Onishi, A., Nozaki, Y., Itami, T., Ebina, K., Etani, Y., Yamada, H., et al. (2026) · Lara D. Veeken · doi:10.1093/rheumatology/keag498 · Cited by 2 · see citing works

Exploring the Mechanisms of the Huangqin Qingfei Decoction in Pneumonia Treatment for Lipopolysaccharide-Induced Mouse Model: A Network Pharmacology Analysis and Experimental Validation

Zheng, Z., Lei, J., Chang, J., Yi, X.-X., Zhou, G., & Chen, J. (2024) · Natural Product Communications · doi:10.1177/1934578x241239843 · Cited by 2 · see citing works

Castleman Disease—Still More Questions than Answers: A Case Report and Review of the Literature

Sikora, M., Dąbrowska-Leonik, N., Buda, P., Wolska‐Kuśnierz, B., Jahnz‐Różyk, K., Pac, M., & Więsik–Szewczyk, E. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082799 · Cited by 3 · see citing works

Baseline erythrocyte sedimentation rate level predicts long-term inhibition of radiographic progression by tocilizumab: the KURAMA cohort

Watanabe, R., Murakami, K., Fujisaki, T., Ito, H., Murata, K., Yamamoto, W., Fujii, T., Onizawa, H., Ōnishi, A., Tanaka, M., et al. (2023) · Immunological Medicine · doi:10.1080/25785826.2023.2170384 · Cited by 2 · see citing works

Construction and validation of a diagnostic model for rheumatoid arthritis based on mitochondrial autophagy-related genes

In, I. I., & Deng, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24818 · Cited by 2 · see citing works

COVID‐19 hospitalization with later long COVID in a person with Down syndrome

Amin, M. A., Khan, I. I., Nahin, S., Bonna, A. S., Afrin, S., & Hawlader, M. D. H. (2022) · Clinical Case Reports · doi:10.1002/ccr3.6425 · Cited by 1 · see citing works

JAK/STAT Signaling Predominates in Human and Murine Fungal Post-infectious Inflammatory Response SyndromePreprint

Hargarten, J. C., Ssebambulidde, K., Anjum, S. H., Vaughan, M. J., Xu, J., Song, B., Ganguly, A., Park, Y., Scott, T. L., Hammoud, D. A., et al. (2024) · medRxiv · doi:10.1101/2024.01.18.24301483 · Cited by 2 · see citing works

Investigation of the putative functional relevance of the IL-6 3'UTR genetic variants with athletic phenotype in Turkish triathletes

Pirim, D., Niş, H. F., & Bağcı, F. A. (2024) · Trakya University Journal of Natural Sciences · doi:10.23902/trkjnat.1493225 · Cited by 1 · see citing works

Development of luciferase-based highly sensitive reporters that detect ER-associated protein biogenesis abnormalities

Kadokura, H., Harada, N., Yamaki, S., Hirai, N., Tsukuda, R., Azuma, K., Amagai, Y., Nakamura, D., Yanagitani, K., Taguchi, H., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111189 · Cited by 2 · see citing works

RECK as a Potential Crucial Molecule for the Targeted Treatment of Sepsis

Qin, Y., Liao, S., Sun, J., Ye, H., Li, J., Pan, J., He, J., Xia, Z., & Shao, Y. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s501856 · Cited by 1 · see citing works

Cognitive impairment in Sjogren’s syndrome: Interplay between BACE1 activity, inflammatory blood biomarkers and neurocognitive testing

Kooshki, A., Yousefi, M., Farmani, R., Kabiri-Rad, H., Nezami, H., Zardast, A., & Saremi, Z. (2025) · PLoS ONE · doi:10.1371/journal.pone.0328311 · Cited by 1 · see citing works

Interleukin-6: From arthritis to CAR-T cell therapy and COVID-19

Kishimoto, T. (2021) · International Immunology · doi:10.1093/intimm/dxab011 · Cited by 18 · see citing works

Interleukin (IL-6) ImmunotherapyPreprint

Tanaka, T., Narazaki, M., & Kishimoto, T. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028456 · Cited by 407 · see citing works

Pathogenetic significance of the use of a humanized monoclonal antibody to the IL-6-α receptor (tocilizumab) in the treatment of immuno-inflammatory diseases

Vi, M., Belyaeva, I. B., Samigullina, R. R., Леонидович, Ч. А., & Dadalova, A. M. (2020) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2020-8-102-112 · Cited by 1 · see citing works

Interleukin-6 inhibitors: from the therapy of immuno-inflammatory rheumatic diseases to use in COVID-19

Muravyeva, N., & Belov, B. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-11-88-94

Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms

Kang, S., & Kishimoto, T. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00649-0 · Cited by 382 · see citing works